Motivational Interviewing to Acutely Admitted Psychiatric Patients With Comorbid Substance Use

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00184223

Enrollment

135

Registered

2005-09-16

Start date

2004-10-31

Completion date

2005-06-30

Last updated

2016-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance-Related Disorders

Keywords

Motivational Interviewing, Substance abuse, Acuteley admitted psychiatric patients, Emergency Services, Psychiatric

Brief summary

The purpose for this study is to determine whether 2x45 minutes Motivational Interviewing given during hospital stay to acutely admitted psychiatric patients with substance use problems, can reduce substance use after discharge.

Detailed description

The aims of the study are in a randomized controlled trial to compare the effects of 2 x 45 minutes Motivational Interviewing and standard treatment with standard treatment alone.All patients acutely admitted to Østmarka Psychiatric Hospital are evaluated for substance use, and all patients with substance use that give their consent to participate are randomized to Motivational Interviewing and standard treatment or standard treatment alone. Substance use and function will be followed for two years.Admittances to hospital and contacts with primary health care for five years.

Interventions

BEHAVIORALMotivational Interviewing

2 sessions of 45 minutes each with manual guided motivational interviewing delivered individually by a trained therapist.

OTHERTreatment as usual

Treatment as usual is individualized according to the clinical condition of the patients during the stay and in accordance with general national and international medical standards. It includes detoxification, pharmacotherapy, and general psychotherapy. Also, treatment is given for any coexisting non-substance-related disorder, including psychiatric disorders.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Caregiver)

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* substance use * acutely admitted to psychiatric hospital

Exclusion criteria

* dementia * serious brain damage * not speaking Norwegian or English

Design outcomes

Primary

Measure	Time frame
Substance use and function questionnaire	2 years

Secondary

Measure	Time frame
Admissions to hospital	2 years
Number of contacts with primary ealth care	2 years

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026